FDA Adjusts Stance on Buprenorphine, Methodone for Opioid Addiction
September 20th 2017Buprenorphine and methadone — while linked to increased risk of serious side effects — are more beneficial than harmful when combined with benzodiazepines or other central nervous system depressants for opioid addiction care.
Read More
Dupilumab Treats Asthma Exacerbation, Lung Function in Phase 3 Trial
September 11th 2017About one million US adults and adolescents live with uncontrolled, persistent asthma — despite there already being an intensive regimen of standard therapies. Dupilumab may be a missing piece to comprehensive treatment.
Read More